SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-036526
Filing Date
2017-07-12
Accepted
2017-07-12 13:37:21
Documents
3
Period of Report
2017-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v470683_8k.htm 8-K 21723
2 EXHIBIT 10.1 v470683_ex10-1.htm EX-10.1 328525
3 EXHIBIT 99.1 v470683_ex99-1.htm EX-99.1 12415
  Complete submission text file 0001144204-17-036526.txt   363920
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36602 | Film No.: 17961543
SIC: 2834 Pharmaceutical Preparations